v3.26.3
Segment Information (Segment Data) (Details) - USD ($)
$ in Millions
 3 Months Ended 9 Months Ended
Sep. 25, 2026
Sep. 26, 2025
Sep. 25, 2026
Sep. 26, 2025
Dec. 31, 2025
Segment Reporting [Line Items]          
Sales $ 6,554 $ 6,053 $ 18,770 $ 17,730  
Less:          
Depreciation (208) (189) (597) (555)  
Amortization of intangible assets (513) (433) (1,410) (1,269)  
Impairments (52) (101) (52) (548)  
Acquisition-related items (84)   (209)    
Other segment items (4,452) (4,176) (12,786) (12,170)  
Operating profit 1,245 1,154 3,716 3,188  
Identifiable assets 93,281   93,281   $ 83,464
Capital expenditures 255 292 761 785  
Operating segments          
Segment Reporting [Line Items]          
Sales 6,554 6,053 18,770 17,730  
Less:          
Depreciation (205) (186) (590) (548)  
Amortization of intangible assets (513) (433) (1,410) (1,269)  
Impairments (52) (101) (52)    
Acquisition-related items (84)   (209)    
Other segment items (4,350) (4,094) (12,510) (11,920)  
Operating profit 1,350 1,239 3,999 3,445  
Other          
Segment Reporting [Line Items]          
Sales 0 0 0 0  
Less:          
Depreciation (3) (3) (7) (7)  
Amortization of intangible assets 0 0 0 0  
Impairments 0 0 0 0  
Acquisition-related items 0   0    
Other segment items (102) (82) (276) (250)  
Operating profit (105) (85) (283) (257)  
Identifiable assets 9,347   9,347   8,267
Capital expenditures 0 1 3 4  
Biotechnology | Operating segments          
Segment Reporting [Line Items]          
Sales 1,807 1,798 5,524 5,260  
Less:          
Depreciation (44) (38) (124) (110)  
Amortization of intangible assets (227) (231) (692) (672)  
Impairments (52) (86) (52) (101)  
Acquisition-related items 0   0    
Other segment items (1,007) (1,091) (3,089) (3,053)  
Operating profit 477 352 1,567 1,324  
Identifiable assets 35,504   35,504   37,337
Capital expenditures 56 94 186 255  
Life Sciences | Operating segments          
Segment Reporting [Line Items]          
Sales 1,865 1,792 5,481 5,249  
Less:          
Depreciation (48) (47) (144) (137)  
Amortization of intangible assets (153) (154) (456) (453)  
Impairments 0 0 0 (432)  
Acquisition-related items 0   0    
Other segment items (1,405) (1,369) (4,153) (4,043)  
Operating profit 259 222 728 184  
Identifiable assets 22,645   22,645   23,112
Capital expenditures 44 40 109 129  
Diagnostics | Operating segments          
Segment Reporting [Line Items]          
Sales 2,882 2,463 7,765 7,221  
Less:          
Depreciation (113) (101) (322) (301)  
Amortization of intangible assets (133) (48) (262) (144)  
Impairments 0 (15) 0 (15)  
Acquisition-related items (84)   (209)    
Other segment items (1,938) (1,634) (5,268) (4,824)  
Operating profit 614 665 1,704 1,937  
Identifiable assets 25,785   25,785   $ 14,748
Capital expenditures $ 155 $ 157 $ 463 $ 397